Brightview Veteran Services logo
Depression Nexus Letters

Depression Secondary to Medication for a Service-Connected Condition

If the VA granted a condition, prescribed a medication for it, and your mood changed afterward, the causal chain may run through service. It is one of the least-filed theories in VA claims, because recognizing it requires reading the pharmacology.

Request a free consultation Call (919) 849-8617
Prescription pill bottles on a counter
Written by Dr. Jessica R. Allen, M.D. — licensed psychiatrist and former VA Compensation & Pension examiner. · Last reviewed August 22, 2026.

Direct answer

Can depression caused by medication be service-connected?

Under 38 CFR 3.310, a disability resulting from treatment for a service-connected condition can itself be service-connected. Where a medication prescribed for a granted condition causes or aggravates a depressive disorder, that depression is compensable. The evidence differs sharply by drug — mefloquine, interferon alfa, corticosteroids, and efavirenz carry well-documented neuropsychiatric effects, while several drugs commonly named in these claims are genuinely contested in the literature. An opinion that treats all of them as equally established is easier to discount than one that says which is which. Depression nexus letters can describe pharmacology and pathophysiology to help veterans get depression service-connected.

Before anything else: nothing on this page is guidance about your own prescriptions. Do not start, stop, or change any medication based on what you read here. If you are concerned about a medication's effect on your mood, that is a conversation with the physician who prescribed it. This page is about how a VA claim is documented, not about how you should be treated.

The regulation

How does a medication pathway work as a VA claim?

Section 3.310(a) service-connects a disability proximately due to a service-connected condition. Section 3.310(b) covers aggravation — a service-connected condition worsening something beyond its natural progression, with Allen v. Brown, 7 Vet. App. 439 (1995), as the controlling authority.

A medication claim runs through the same regulation, with one extra link in the chain. The VA granted a condition. Treatment for that condition was medically indicated. The treatment contributed to a depressive disorder. Each link has to be documented, and the middle one is where these claims are usually strongest — if the VA rated the condition, it can hardly dispute that the condition needed treating.

There is a second, quieter version of this pathway that is often the more accurate one. Sedating medications, or the sleep disruption and functional losses that come with the underlying condition, can produce fatigue, anhedonia, and cognitive slowing that meet depressive criteria without any direct pharmacological mechanism at all. That route is frequently easier to defend than a direct drug effect, and an honest opinion will sometimes conclude that is what happened.

In plain terms

You are not claiming that a drug is dangerous. You are claiming that treatment the VA's own rating decision made necessary had a consequence, and that the consequence is compensable. Those are different arguments, and only the second one is a VA claim.

The evidence

Which medications are associated with depression?

The candor here matters more than the length of the list. Under McCray v. Wilkie, an examiner is expected to engage the literature honestly, including the parts that cut against the conclusion. An opinion that presents a contested association as settled invites the examiner to discount the whole report. See also why medical literature alone is not enough.

Medication pathways and the state of the evidence
MedicationCommonly prescribed forEvidence
Mefloquine(Lariam)Malaria prophylaxis during deploymentWell establishedCarries an FDA boxed warning for neurologic and psychiatric adverse reactions added in 2013, with a caution that some neurologic effects may persist after the drug is stopped.
Interferon alfaHepatitis C, some malignanciesWell establishedDepression during treatment is among the most extensively documented drug-induced mood effects in medicine.
CorticosteroidsInflammatory and autoimmune conditions, severe asthmaWell establishedMood disturbance is dose-related and more likely with higher doses and prolonged courses.
EfavirenzHIVWell establishedNeuropsychiatric effects including mood symptoms and sleep disturbance are recognized in the labeling.
Long-term opioid therapyChronic painConsistent associationNew-onset and worsening depression are consistently reported, though separating the drug effect from the underlying pain condition requires care in an individual case.
IsotretinoinSevere acnePossible associationPossible association — Case reports and regulatory labeling have raised concern for a possible association with depressive symptoms; however, controlled studies have not consistently demonstrated a causal relationship. Any medical opinion should characterize the evidence as an association rather than establish direct causation.
Beta blockersHypertension, cardiac conditionsPossible associationPossible association — Beta blockers have historically been associated with depressive symptoms, although more recent analyses have not consistently demonstrated a clear causal or depressogenic effect. The literature supports describing this as a possible association rather than a definitive cause-and-effect relationship.

Educational summary of the literature as it stands. Whether any medication contributed in a particular veteran depends on dose, duration, timing relative to symptom onset, and what else was occurring in that period.

Building the opinion

What does a medication-based depression opinion have to establish?

  1. 1

    That the medication was prescribed for a service-connected condition

    The rating decision granting the underlying condition, plus pharmacy records, treatment notes, or — where unit-level dispensing means no individual record exists — deployment history and corroborating statements.

  2. 2

    A temporal relationship that actually holds up

    When the medication started, when the mood symptoms began, and whether the sequence fits the known onset pattern for that drug. A depressive disorder documented years before the prescription is not caused by it, and an opinion that ignores the dates will not survive review.

  3. 3

    Dose and duration

    Several of these associations are dose-dependent. A single short course of corticosteroids and two years of high-dose therapy are not the same exposure, and an opinion that does not distinguish them is asserting rather than reasoning.

  4. 4

    What happened when the medication changed

    If symptoms improved after discontinuation, that is meaningful. If they did not, that also has to be addressed — for some drugs, including mefloquine, persistence after discontinuation is consistent with the known profile rather than evidence against the pathway.

  5. 5

    The alternative explanations, named honestly

    The underlying condition itself. Chronic pain. Sleep disruption. A divorce or job loss in the same window. Hypothyroidism or another medical cause. An opinion that pretends the drug was the only variable reads as advocacy; one that weighs the contributors and explains the relative role of the service-connected exposure reads as medicine.

  6. 6

    The diagnosis, demonstrated rather than named

    Each DSM-5 criterion addressed against specific evidence in the record, with the exclusion criteria — another medical condition, another substance — actually considered rather than skipped.

Not sure what you were prescribed, or when?

Bring what you have — the rating decision, any pharmacy records, your deployment history. Dr. Allen will tell you whether the pathway is supportable, including when it is not.

Request a free consultationCall (919) 849-8617

Why these claims get denied

  • A drug effect is asserted without addressing dose, duration, or timing.
  • A contested association is presented as settled science.
  • The medication was prescribed for a condition the VA has not service-connected.
  • Alternative explanations — the underlying condition, pain, sleep loss, life events — are never named.
  • No individual prescription record exists, and nothing else is offered in its place.

What's in a Brightview opinion

  • The rating decision and the prescription tied together as one documented chain.
  • A symptom timeline read against the known onset pattern for that drug.
  • Dose and duration addressed directly, not glossed over.
  • The literature engaged honestly, including where it is contested.
  • Alternative causes weighed, with the relative role of the service-connected exposure explained.
  • Each DSM-5 criterion demonstrated against specific evidence in the record.

FAQ

Frequently asked questions about medication-related depression claims

Can I get VA disability for depression caused by medication?

Where the medication was prescribed for a service-connected condition, yes — 38 CFR 3.310 service-connects a disability resulting from treatment for a service-connected condition. The claim requires evidence that the medication was prescribed for the granted condition, a temporal relationship that holds up, and a medical opinion explaining the mechanism and addressing alternative explanations. A medication prescribed for a condition the VA has not service-connected does not create this pathway.

Which medications are most associated with depression?

The best-established are mefloquine, interferon alfa, corticosteroids, and efavirenz, each with documented neuropsychiatric or mood effects. Long-term opioid therapy shows a consistent association with new-onset and worsening depression, though separating the drug effect from the underlying pain condition takes care. Isotretinoin and beta blockers are frequently named in claims but are contested in the literature, and a credible opinion says so rather than asserting causation.

What is mefloquine and why does it matter for veterans?

Mefloquine, marketed as Lariam, is an antimalarial that was widely used for prophylaxis among service members deploying to malaria-risk regions. In 2013 the FDA added a boxed warning for neurologic and psychiatric adverse reactions, noting that neurologic effects may persist or become permanent after the drug is stopped, and the Department of Defense subsequently made it a drug of last resort. Both changes came after most of the affected deployments. It matters for claims because it was often dispensed weekly at the unit level, so many veterans took it without an individual prescription record.

What if the medication isn't in my service treatment records?

That is common, particularly with unit-level malaria prophylaxis. The pathway can be established through deployment location and dates, the prophylaxis regimen in use for that theater at that time, statements from those who served with you, and contemporaneous complaints in the record — vivid dreams, insomnia, anxiety, dizziness — that are often filed under something else entirely. Absence of a prescription line is not proof the medication was never taken.

Does it matter how long I took the medication?

Yes. Several of these associations are dose- and duration-dependent, corticosteroids most clearly. A single short course and two years of high-dose therapy are different exposures, and an opinion that does not distinguish them is asserting rather than reasoning. Dose and duration are among the first things a reviewing examiner will look for.

What if my symptoms didn't go away after I stopped the medication?

That does not necessarily defeat the claim. For some drugs, including mefloquine, persistence after discontinuation is consistent with the known profile rather than evidence against the pathway. What matters is that the opinion addresses the question directly instead of leaving it for the examiner to raise.

Can I claim this if the depression is also related to my pain or my sleep?

Yes, and multifactorial causation is the norm rather than the exception. An opinion that names the contributors honestly and explains the relative role of the service-connected exposure is more persuasive than a single-cause story that ignores half the record. The underlying condition, the medication treating it, and the functional losses that follow can all contribute at once, and each is a route back to service.

Should I stop taking the medication to strengthen my claim?

No. Do not start, stop, or change any prescription because of a VA claim or because of anything on this page. Medications are prescribed for reasons, and stopping one can carry real medical risk. If you are concerned about a medication's effect on your mood, raise it with the physician who prescribed it. A claim is documented from the record as it is, not from changes made to improve it.

Who should write a medication-based depression opinion?

These questions sit inside the practice of medicine. Drug mechanism, dose-response, onset patterns, and differential diagnosis against a general medical cause are pharmacological and clinical questions, and an opinion on them is stronger from a physician — particularly a psychiatrist, for whom psychotropic and mood-affecting medications are daily work. Under Nieves-Rodriguez v. Peake, an examiner's training, specialty, familiarity with the facts, and quality of reasoning all bear on how persuasive the opinion is.

What if my claim for this was already denied?

Medication theories are often denied because the prior opinion asserted a drug effect without addressing dose, duration, timing, or alternative causes — or because it presented a contested association as settled. A rebuttal opinion can respond to that reasoning point by point. The rating decision itself is the most useful document you have, because it states which element the VA found missing.

Where to go next

Related pages

Main pageDepression Nexus LettersAll pathways to service connection for depression — direct, secondary, and aggravation.Reverse side effectHemorrhoids Secondary to Pain MedicationWhen the opioid treating the pain condition causes constipation and hemorrhoids instead of depression.SecondaryDepression Secondary to Chronic PainThe condition being treated is often a pathway in its own right, alongside the treatment.Who writes itWhy the Author of a Depression Nexus Letter MattersWhere specialty changes how much weight an opinion carries.Denied claimsRebuttal Nexus OpinionsResponding point by point to an unfavorable C&P opinion or rating decision.

About the author

Jessica R. Allen, M.D.

Licensed psychiatrist and former VA Compensation and Pension examiner · Brightview Psychiatry Solutions PLLC, Wake Forest, North Carolina

Dr. Allen spent three years conducting Compensation and Pension examinations for the VA, and has spent the six years since writing independent medical opinions for veterans. Medication pathways are among the claims she is asked about least and finds most often, because the drug list is usually the one part of a file nobody has read against the symptom timeline. More about Dr. Allen.

Start with a free consultation

Bring your rating decision and whatever medication history you have. Dr. Allen will tell you whether the pathway is supportable — including when it is not.

Request a Consultation Call (919) 849-8617

Brightview Psychiatry Solutions PLLC provides independent medical opinions and psychiatric evaluations. This page is educational and is not medical or legal advice, and does not create a physician-patient relationship. VA determines service connection and assigns all disability evaluations. No outcome is guaranteed.

Book a Consultation